Consequently, over 50% of all human cancer cases can be attributed to an acquired loss-of-function (LOF), with missense TP53 mutations resulting in impairments to adequately repair DNA damage, regulate cell division, and/or effectively eliminate cancer cells through apoptosis [2]. This evidence concerns the gene TP53 and cancer.